1. A review of genome-wide transcriptomics studies in Parkinson's disease
   Genevie Borrageiro et al, 2017, Eur J Neurosci CrossRef
2. Sampling Defective Pathways in Parkinson Disease
   Juan Luis Fernández-Martínez et al, 2019, JMID CrossRef
3. Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
   Jack Kelly et al, 2019, Mol Brain CrossRef
4. The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
   Ye Tao et al, 2020, Front. Neurol. CrossRef
5. Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis
   Min Sun et al, 2017, Oncotarget CrossRef
6. Functional gene networks reveal distinct mechanisms segregating in migraine families
   Andreas H Rasmussen et al, 2020 CrossRef
7. Identifying potential gene biomarkers for Parkinson’s disease through an information entropy based approach
   A Monaco et al, 2020, Phys. Biol. CrossRef
8. Meta-Analysis of Differentially Expressed Genes in the Substantia Nigra in Parkinson’s Disease Supports Phenotype-Specific Transcriptome Changes
   Duong My Phung et al, 2020, Front. Neurosci. CrossRef
9. N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions
   Bingying Du et al, 2021, Aging CrossRef
10. Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson’s disease
    Gabriela Novak et al, 2022, Commun Biol CrossRef
11. Proteins and Transcriptional Dysregulation of the Brain Extracellular Matrix in Parkinson’s Disease: A Systematic Review
    Wote Amelo Rike et al, 2023, IJMS CrossRef
12. Compositional Features and Codon Usage Pattern of Genes Associated with Parkinson’s Disease
    Arif Uddin, 2024, Mol Neurobiol CrossRef
13. Trends in drug development for rare and intractable diseases based on the KEGG NETWORK
    Mao Tanabe et al, 2024 CrossRef